We are live on ! Find out more
CAI

Caris Life Sciences
CAI

116 hedge funds and large institutions have $2.92B invested in Caris Life Sciences in 2025 Q2 according to their latest regulatory filings, with 116 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

38.56% more ownership

Funds ownership: 0% → 38.56% (+39%)

99% less call options, than puts

Call options by funds: $26K | Put options by funds: $2.06M

Holders
116
Holders Change
+116
Holders Change %
–
% of All Funds
1.53%
Holding in Top 10
6
Holding in Top 10 Change
+6
Holding in Top 10 Change %
% of All Funds
0.08%
New
116
Increased
–
Reduced
–
Closed
–
Calls
$26K
Puts
$2.06M
Net Calls
-$2.03M
Net Calls Change
-$2.03M

Top Buyers

Rank Fund Capital Flow
1
SSP
Sixth Street Partners
Texas
+$657M
2
Coatue Management
Coatue Management
New York
+$273M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$233M
4
B
Braidwell
Connecticut
+$197M
5
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$197M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RSCM
26
Rock Springs Capital Management
Maryland
$21.2M +$21.4M +793,651 New
Franklin Resources
27
Franklin Resources
California
$14.1M +$14.2M +527,039 New
Invesco
28
Invesco
Georgia
$13.5M +$13.7M +506,737 New
Point72 Asset Management
29
Point72 Asset Management
Connecticut
$12.3M +$12.4M +458,476 New
FLAM
30
First Light Asset Management
Minnesota
$11.2M +$11.9M +443,043 New
Alyeska Investment Group
31
Alyeska Investment Group
Illinois
$10M +$10.1M +376,000 New
Norges Bank
32
Norges Bank
Norway
$10M +$10.1M +375,000 New
Citadel Advisors
33
Citadel Advisors
Florida
$9.13M +$9.21M +341,570 New
BlackRock
34
BlackRock
New York
$8.26M +$8.33M +309,102 New
SPPAM
35
Summit Partners Public Asset Management
Massachusetts
$7.91M +$7.98M +296,000 New
Fidelity International
36
Fidelity International
Bermuda
$7.91M +$7.98M +295,971 New
Jennison Associates
37
Jennison Associates
New York
$7.66M +$7.72M +286,624 New
Tudor Investment Corp
38
Tudor Investment Corp
Connecticut
$7.07M +$7.13M +264,551 New
Geode Capital Management
39
Geode Capital Management
Massachusetts
$6.29M +$6.34M +235,234 New
TD Asset Management
40
TD Asset Management
Ontario, Canada
$5.34M +$5.39M +199,824 New
Goldman Sachs
41
Goldman Sachs
New York
$4.87M +$4.91M +182,253 New
Holocene Advisors
42
Holocene Advisors
New York
$4.62M +$4.66M +172,943 New
Lazard Asset Management
43
Lazard Asset Management
New York
$4.54M +$4.58M +169,929 New
Adage Capital Partners
44
Adage Capital Partners
Massachusetts
$4.01M +$4.04M +150,000 New
State of Wisconsin Investment Board
45
State of Wisconsin Investment Board
Wisconsin
$4.01M +$4.04M +150,000 New
Vanguard Group
46
Vanguard Group
Pennsylvania
$4.01M +$4.04M +150,000 New
Aberdeen Group
47
Aberdeen Group
United Kingdom
$3.15M +$3.18M +117,841 New
CM
48
CastleKnight Management
New York
$3.03M +$3.06M +113,430 New
HF
49
HRT Financial
New York
$2.92M +$2.95M +109,318 New
Blackstone Inc
50
Blackstone Inc
New York
$2.67M +$2.69M +100,000 New
1
2
3 4 5

CAI Hedge Fund Activity: Q2 2025 in Review

116 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Caris Life Sciences (CAI) for Q2 2025, worth a combined $2.92B.

Buyers outnumbered sellers: 116 funds opened new CAI positions and 0 closed out — a net gain of 116 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Sixth Street Partners, opening a new position worth an estimated $657M.

  • 116 institutional investors held Caris Life Sciences (CAI) as of Q2 2025, up from 0 in Q1 2025.
  • Funds reported $2.92B of Caris Life Sciences stock for Q2 2025.
  • 116 funds opened new Caris Life Sciences positions in Q2 2025 and 0 closed out, a net change of +116 holders.
  • The largest Caris Life Sciences buyer in Q2 2025 was Sixth Street Partners, an estimated $657M added.

Based on aggregated 13F filings for Q2 2025.